Does IMATINIB Cause Lung neoplasm malignant? 103 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 103 reports of Lung neoplasm malignant have been filed in association with IMATINIB (Imatinib). This represents 0.2% of all adverse event reports for IMATINIB.
103
Reports of Lung neoplasm malignant with IMATINIB
0.2%
of all IMATINIB reports
38
Deaths
15
Hospitalizations
How Dangerous Is Lung neoplasm malignant From IMATINIB?
Of the 103 reports, 38 (36.9%) resulted in death, 15 (14.6%) required hospitalization, and 4 (3.9%) were considered life-threatening.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMATINIB. However, 103 reports have been filed with the FAERS database.
What Other Side Effects Does IMATINIB Cause?
Death (9,708)
Drug ineffective (2,628)
Nausea (2,379)
Diarrhoea (2,203)
Fatigue (1,810)
Malignant neoplasm progression (1,716)
Vomiting (1,599)
Malaise (1,361)
Drug intolerance (1,354)
Drug resistance (1,293)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which IMATINIB Alternatives Have Lower Lung neoplasm malignant Risk?
IMATINIB vs IMBRUVICA
IMATINIB vs IMDEVIMAB
IMATINIB vs IMEGLIMIN
IMATINIB vs IMETELSTAT
IMATINIB vs IMIDAPRIL